STOCK TITAN

Agape ATP Corporation 8-K Filings

ATPC NASDAQ

Every 8-K that Agape ATP Corporation (ATPC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ATPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATPC filings page.

Rhea-AI Summary

Agape ATP Corporation reported that Nasdaq has confirmed the company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company had previously received Nasdaq notices in January and February 2026 citing a bid price below $1.00 per share and a closing bid of $0.10 or less for ten consecutive trading days under the “Low Priced Stocks” rule.

Following the March 10, 2026 letter from the Nasdaq Hearings Advisor, the scheduled March 17, 2026 hearing has been cancelled, and the company’s common stock will continue trading on Nasdaq under the symbol ATPC.

Rhea-AI Summary

Agape ATP Corporation, through its wholly owned subsidiary ATPC Green Energy Sdn. Bhd., has entered into a non-exclusive Collaboration Agreement with Citadel Investment LLC, a Dubai-based investment and global commodities trading firm, effective March 2026.

The parties plan to cooperate on the sale and purchase of oil, gas, refinery and petrochemical products by leveraging their respective commercial networks to identify, structure and facilitate cross-border energy transactions. The agreement outlines commission or profit-sharing for transactions introduced under the partnership and includes provisions on intellectual property, assignment, confidentiality, and protection of clients and business partners introduced by either party.

Rhea-AI Summary

Agape ATP Corporation is implementing a 1-for-50 reverse stock split of its issued and outstanding common stock. Shareholders approved an amendment allowing one or more reverse splits of up to 1-for-5,000, and the board has chosen a 1-for-50 ratio.

The reverse split is expected to become effective on February 9, 2026, with the common stock trading on a split-adjusted basis on the Nasdaq Capital Market beginning February 10, 2026, under the same symbol “ATPC.” No fractional shares will be issued; any fraction will be rounded up to the nearest whole share, and the authorised common share count will remain unchanged.

Following the reverse split, the common stock will receive a new CUSIP number, 008389306, and outstanding equity awards will be proportionately adjusted for both share amounts and exercise prices.

Rhea-AI Summary

Agape ATP Corporation has received a determination from Nasdaq staff to delist its securities after a prolonged share price decline. The decision follows an earlier notice that the company failed to meet Nasdaq’s minimum bid price requirement of $1.00 per share.

Nasdaq staff cited that, as of January 30, 2026, Agape ATP’s securities had a closing bid of $0.10 or less for ten consecutive trading days, triggering Nasdaq’s Low Priced Stocks rule. The company plans to request a hearing by February 9, 2026, which will temporarily prevent suspension and a Form 25-NSE filing while a panel reviews the case.

Rhea-AI Summary

Agape ATP Corporation held its Annual Meeting of Stockholders on January 30, 2026, where all matters submitted to a vote were approved. One key proposal received 30,095,479 votes for, 50 against and 421 abstentions, indicating near-unanimous support.

Stockholders also elected directors including How Kok Choong, who received 29,562,792 votes for, 2,898 withheld votes and 421 abstentions, with similar strong support levels for the other board nominees.

Rhea-AI Summary

Agape ATP Corporation reported that Nasdaq has notified the company it no longer meets the continued listing requirement to maintain a minimum bid price of $1 per share under Nasdaq Listing Rule 5550(a)(2). The notice is based on closing bid prices from December 10, 2025 to January 26, 2026.

The company has 180 calendar days, until July 27, 2026, to regain compliance. If it meets other Nasdaq Capital Market listing standards, it may qualify for an additional 180‑day period and could use measures such as a reverse stock split. Failing to regain compliance could lead to delisting. Agape ATP is evaluating options and intends to regain compliance, but there is no assurance it will succeed.

Rhea-AI Summary

Agape ATP Corporation issued a press release on December 12, 2025 titled “Agape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook.” The company furnished this press release as Exhibit 99.1 to a current report so readers can review its statement on recent market conditions and its reaffirmed strategic plans.